January 19, 20215 yr [hide] FDA approves Sinovac's COVID-19 vaccine for clinical trials Published January 19, 2021 1:53pm Updated January 19, 2021 2:45pm By JOVILAND RITA, GMA News The Food and Drug Administration (FDA) has approved the application of Chinese drug manufacturer Sinovac Biotech to conduct clinical trials of its COVID-19 vaccine in the Philippines. At the Laging Handa briefing on Tuesday, FDA director general Eric Domingo said all applications for the conduct of clinical trials in the country have been approved, including Sinovac's. “Lahat ng nag-apply ng clinal trials sa FDA, na-approve na po 'yan,” Domingo said. “So I would presume nag-uumpisa na po 'yan. ‘Yan po si Janssen ng Johnson and Johnson, ‘yung pong Clover Pharmaceutical, tsaka 'yun pong Sinovac. Meron din po silang clinal trial dito,” he added. In October last year, the Vaccine Expert Panel (VEP) under the Department of Science and Technology (DOST) cleared Sinovac for clinical trials, elevating the process to the Ethics Board and the FDA. [/hide]
Create an account or sign in to comment